Imprimis Pharma secures $9.8M private capital raise

• Imprimis Pharmaceuticals (NASDAQ:IMMY-OLD) inks an agreement with investors, including certain board members, the CEO, CFO and Senior Director of Corporate Development, for the direct placement of 5.1M Units to raise ~$9.8M.
• Each Unit consists of one share of common stock and one three-year warrant to purchase one share of common at $1.79 at a combined price of $1.915.
• Net proceeds will fund its ophthalmology business and general corporate purposes.
• Today's close was $2.82 so investors should expect a down day on Tuesday.